SCHEMBL3577616

SCHEMBL3577616

NC(=O)c1ccccc1CCc1cccc(OC(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.47
CHRM2 P08172 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
GPR52 Q9Y2T5 1/20 0.46
CNR1 P21554 1/20 0.46
MAPK14 Q16539 1/20 0.46
SCN9A Q15858 2/20 0.45
KDM5A P29375 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
KDM5B Q9UGL1 1/20 0.45
EPHX1 P07099 1/20 0.45
AMPD2 Q01433 1/20 0.44
KMT2A Q03164 1/20 0.44
SIRT2 Q8IXJ6 2/20 0.43
PLA2G10 O15496 1/20 0.43
PLA2G2A P14555 1/20 0.43
PLA2G5 P39877 1/20 0.43
CETP P11597 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3578190 0.86 DAO (0.49) DAOKMT2ASIRT2PLA2G10PLA2G2A
SCHEMBL8165166 0.83 PLA2G4A (0.46) TRPM8MAPK14KDM5AKDM4CKDM5B
SCHEMBL5685633 0.83 ABCB1 (0.58)
SCHEMBL3576444 0.81 GPR52 (0.50) DAOTRPM8CHRM2CHRM1CHRM3
SCHEMBL3233027 0.80 SIRT2 (0.54) GPR52EPHX1KMT2ASIRT2
SCHEMBL29818302 0.78 SIRT2 (0.51) DAOKMT2ASIRT2
SCHEMBL30487710 0.78 CHRM2 (0.52) DAOTRPM8CHRM2CHRM1CHRM3
SCHEMBL5724443 0.78 CHRM2 (0.52) DAOTRPM8CHRM2CHRM1CHRM3
SCHEMBL934552 0.77 CHRM2 (0.51) DAOTRPM8CHRM2CHRM1CHRM3
Trifluoroacetic Acid SCHEMBL15568420 0.76 ALDH1A1 (0.51) KMT2ASIRT2FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219261-A1 Anthranilamide and 2-amino-heteroarene-carboxamide compounds AADAT, AAAS, AADAC DAO 594/4885TRPM8 1917/4885CHRM2 1474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.